{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:49:12Z","timestamp":1793396952464,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Adelphi Communications, LLC"},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.rmed.2016.08.022","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T04:27:57Z","timestamp":1472531277000},"page":"S1-S9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"special_numbering":"S1","title":["Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence"],"prefix":"10.1016","volume":"122","author":[{"given":"Peter","family":"Sandner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Peter","family":"Stasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rmed.2016.08.022_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.rmed.2016.08.022_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research \u2013 still expanding after half a century","volume":"3","author":"Beavo","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5789","key":"10.1016\/j.rmed.2016.08.022_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.rmed.2016.08.022_bib4","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.rmed.2016.08.022_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.RES.60.1.82","article-title":"Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein","volume":"60","author":"Ignarro","year":"1987","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.rmed.2016.08.022_bib6","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.rmed.2016.08.022_bib7","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib8","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI114081","article-title":"Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells","volume":"83","author":"Garg","year":"1989","journal-title":"J.\u00a0Clin. Investig."},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib9","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1073\/pnas.0304264101","article-title":"Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment","volume":"101","author":"Ahluwalia","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.rmed.2016.08.022_bib10","doi-asserted-by":"crossref","first-page":"H672","DOI":"10.1152\/ajpheart.00198.2011","article-title":"IRAZ and novel PKG targeting in the cardiovascular system","volume":"301","author":"Schlossman","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.rmed.2016.08.022_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-540-68964-5_9","article-title":"cGK substrates","volume":"191","author":"Schlossman","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.rmed.2016.08.022_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature01922","article-title":"Structural basis for modulation and agonist specificity of HCV pacemaker channels","volume":"425","author":"Zagotta","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2016.08.022_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.rmed.2016.08.022_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signaling in cardiovascular disease","volume":"14","author":"Lundberg","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"6","key":"10.1016\/j.rmed.2016.08.022_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","article-title":"Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension","volume":"188","author":"Klinger","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.08.022_bib16","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.100.19.1951","article-title":"Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation","volume":"100","author":"Duffy","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.94.3.266","article-title":"Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina","volume":"94","author":"Kugiyama","year":"1996","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.rmed.2016.08.022_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1 Suppl.","key":"10.1016\/j.rmed.2016.08.022_bib19","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.rmed.2016.08.022_bib20","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"19","key":"10.1016\/j.rmed.2016.08.022_bib22","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMsr1503311","article-title":"Nitroglycerin and nitric oxide\u2014a rondo of themes in cardiovascular therapeutics","volume":"373","author":"Steinhorn","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0704484","article-title":"Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in\u00a0vitro studies","volume":"135","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"6825","key":"10.1016\/j.rmed.2016.08.022_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(03)01674-1","article-title":"Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase","volume":"468","author":"Schmidt","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.rmed.2016.08.022_bib28","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s40265-013-0149-5","article-title":"Riociguat: first global approval","volume":"73","author":"Conole","year":"2013","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.rmed.2016.08.022_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00114407","article-title":"Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension","volume":"32","author":"Schermuly","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2016.08.022_bib30","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2013a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2016.08.022_bib31","doi-asserted-by":"crossref","first-page":"131737","DOI":"10.1155\/2014\/131737","article-title":"Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease","volume":"2014","author":"Sampson","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.rmed.2016.08.022_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0192623391019004-108","article-title":"Cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity","volume":"19","author":"Driscoll","year":"1991","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.rmed.2016.08.022_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-8977-10-3","article-title":"Silica induces NLRP3 inflammasome activation in human lung epithelial cells","volume":"10","author":"Peeters","year":"2013","journal-title":"Part Fibre Toxicol."},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0022-202X(89)90185-1","article-title":"Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta","volume":"92","author":"Duncan","year":"1989","journal-title":"J.\u00a0Investig. Dermatol."},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9440(10)65624-6","article-title":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts","volume":"153","author":"Sime","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.rmed.2016.08.022_bib36","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.175.8.5390","article-title":"TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis","volume":"175","author":"Bonniaud","year":"2005","journal-title":"J.\u00a0Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","article-title":"Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis","volume":"166","author":"Willis","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.2014.43","article-title":"Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis","volume":"94","author":"Chen","year":"2014","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1745-7254.2007.00468.x","article-title":"Effect of TGF-beta\/Smad signaling pathway on lung myofibroblast differentiation","volume":"28","author":"Gu","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1072-7515(98)00303-2","article-title":"Up-regulation by human recombinant transforming growth factor beta-1 of collagen production in cultured dermal fibroblasts is mediated by the inhibition of nitric oxide signaling","volume":"188","author":"Chu","year":"1999","journal-title":"J.\u00a0Am. Coll. Surg."},{"issue":"8","key":"10.1016\/j.rmed.2016.08.022_bib41","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/en.2009-1411","article-title":"Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia","volume":"151","author":"Zenzmaier","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yexcr.2015.08.014","article-title":"Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells","volume":"338","author":"Zenzmaier","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.rmed.2016.08.022_bib43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/annrheumdis-2011-200862","article-title":"Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis","volume":"71","author":"Beyer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.rmed.2016.08.022_bib44","article-title":"Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGF\u03b2 signalling","author":"Beyer","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl.\u00a058","key":"10.1016\/j.rmed.2016.08.022_bib45","first-page":"3423","article-title":"Anti-remodeling potencies of the soluble guanylate cyclase activator BAY 41-2272 in human lung fibroblasts","volume":"44","author":"Lambers","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib46","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1159\/000076405","article-title":"Intracellular cyclic nucleotide analogues inhibit in\u00a0vitro mitogenesis and activation of fibroblasts derived from obstructed rat kidneys","volume":"96","author":"Hewitson","year":"2004","journal-title":"Nephron Exp. Nephrol."},{"issue":"S10","key":"10.1016\/j.rmed.2016.08.022_bib47","first-page":"S387","article-title":"Sildenafil attenuates the fibrotic phenotype in scleroderma skin fibroblasts","volume":"66","author":"Higuchi","year":"2014","journal-title":"Arthr. Rheum."},{"issue":"1","key":"10.1016\/j.rmed.2016.08.022_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2007.06.036","article-title":"Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase","volume":"572","author":"Dunkern","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.HYP.38.2.261","article-title":"Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization","volume":"38","author":"Abdelaziz","year":"2001","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.rmed.2016.08.022_bib50","doi-asserted-by":"crossref","first-page":"e44481","DOI":"10.1371\/journal.pone.0044481","article-title":"The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy","volume":"7","author":"Irvine","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.rmed.2016.08.022_bib51","doi-asserted-by":"crossref","first-page":"16388","DOI":"10.1074\/jbc.M309664200","article-title":"Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3","volume":"279","author":"Feinberg","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5 Pt 1","key":"10.1016\/j.rmed.2016.08.022_bib52","first-page":"L862","article-title":"TGF-beta regulates production of NO in pulmonary artery smooth muscle cells by inhibiting expression of NOS","volume":"268","author":"Finder","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.rmed.2016.08.022_bib53","doi-asserted-by":"crossref","first-page":"L212","DOI":"10.1152\/ajplung.00475.2006","article-title":"Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells","volume":"293","author":"Vyas-Read","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"11","key":"10.1016\/j.rmed.2016.08.022_bib54","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.RES.0000191538.76771.66","article-title":"Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells","volume":"97","author":"Saura","year":"2005","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.rmed.2016.08.022_bib55","doi-asserted-by":"crossref","first-page":"F685","DOI":"10.1152\/ajprenal.00280.2004","article-title":"Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis","volume":"288","author":"Hohenstein","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"9","key":"10.1016\/j.rmed.2016.08.022_bib56","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/HJH.0000000000000648","article-title":"Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia","volume":"33","author":"Stancu","year":"2015","journal-title":"J.\u00a0Hypertens."},{"issue":"1","key":"10.1016\/j.rmed.2016.08.022_bib57","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00197.2005","article-title":"Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition","volume":"290","author":"Wang","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.rmed.2016.08.022_bib58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0706792","article-title":"NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5\/6 nephrectomy","volume":"148","author":"Kalk","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.rmed.2016.08.022_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/hr.2009.64","article-title":"Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart","volume":"32","author":"Masuyama","year":"2009","journal-title":"Hypertens. Res."},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.yexcr.2015.02.006","article-title":"The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2","volume":"232","author":"Zhang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.rmed.2016.08.022_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2012.00128","article-title":"Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress","volume":"3","author":"Costell","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.rmed.2016.08.022_bib62","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/HJH.0b013e32833b558c","article-title":"Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models","volume":"28","author":"Sharkovska","year":"2010","journal-title":"J.\u00a0Hypertens."},{"issue":"7","key":"10.1016\/j.rmed.2016.08.022_bib63","doi-asserted-by":"crossref","first-page":"e21853","DOI":"10.1371\/journal.pone.0021853","article-title":"Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats","volume":"6","author":"Geschka","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib64","first-page":"71","article-title":"Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis","volume":"58","author":"Knorr","year":"2008","journal-title":"Arzneimittelforschung"},{"issue":"4 Suppl.","key":"10.1016\/j.rmed.2016.08.022_bib65","first-page":"755A","article-title":"Antifibrotic effect of the SGC-stimulator bay 41-2272 in the bile duct ligation liver fibrosis model in rats","volume":"54","author":"Nowatzky","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/rccm.200810-1615OC","article-title":"Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis","volume":"181","author":"Sisson","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2016.08.022_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/ajrcmb.24.1.4040","article-title":"Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding","volume":"24","author":"Morishima","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.rmed.2016.08.022_bib68","doi-asserted-by":"crossref","first-page":"L316","DOI":"10.1152\/ajplung.2001.280.2.L316","article-title":"Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor","volume":"280","author":"Kuwano","year":"2001","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6 Pt 1","key":"10.1016\/j.rmed.2016.08.022_bib69","first-page":"L1192","article-title":"Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung","volume":"275","author":"Uhal","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.rmed.2016.08.022_bib70","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1164\/rccm.201212-2297OC","article-title":"Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis","volume":"188","author":"Hung","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2016.08.022_bib71","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"ATS\/ERS\/JRS\/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"35","key":"10.1016\/j.rmed.2016.08.022_bib72","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in\u00a0vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.rmed.2016.08.022_bib73","doi-asserted-by":"crossref","first-page":"e14003","DOI":"10.1371\/journal.pone.0014003","article-title":"Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis","volume":"5","author":"Bocchino","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.rmed.2016.08.022_bib74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/jcp.48.4.330","article-title":"Endothelin-1 in idiopathic pulmonary fibrosis","volume":"48","author":"Uguccioni","year":"1995","journal-title":"J.\u00a0Clin. Pathol."},{"issue":"2 Pt 1","key":"10.1016\/j.rmed.2016.08.022_bib75","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.156.2.9607123","article-title":"Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist","volume":"156","author":"Park","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.08.022_bib76","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","article-title":"Mechanisms of pulmonary fibrosis","volume":"55","author":"Thannickal","year":"2004","journal-title":"Annu. Rev. Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.rmed.2016.08.022_bib77","doi-asserted-by":"crossref","first-page":"O9","DOI":"10.1186\/1471-2210-11-S1-O9","article-title":"Nitric oxide-independent stimulation of soluble guanylate cyclase attenuates pulmonary fibrosis","volume":"11","author":"Evgenov","year":"2011","journal-title":"BMC Pharmacol."},{"issue":"12","key":"10.1016\/j.rmed.2016.08.022_bib78","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u03b2\u2013at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.rmed.2016.08.022_bib79","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.21725","article-title":"Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts","volume":"54","author":"Chen","year":"2006","journal-title":"Arthr. Rheum."},{"issue":"5","key":"10.1016\/j.rmed.2016.08.022_bib80","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.20225","article-title":"An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma","volume":"50","author":"Pannu","year":"2004","journal-title":"Arthr. Rheum."},{"issue":"12","key":"10.1016\/j.rmed.2016.08.022_bib81","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1002\/art.23134","article-title":"Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts","volume":"56","author":"Shi-Wen","year":"2007","journal-title":"Arthr. Rheum."},{"issue":"10","key":"10.1016\/j.rmed.2016.08.022_bib82","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u2013a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J.\u00a0Rheumatol."},{"issue":"3","key":"10.1016\/j.rmed.2016.08.022_bib83","first-page":"831","article-title":"Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.rmed.2016.08.022_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206809","article-title":"Stimulators of soluble guanylate cyclase (sGC) inhibit skin fibrosis of difference aetiologies","author":"Dees","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"suppl. 2","key":"10.1016\/j.rmed.2016.08.022_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2015-eular.2345","article-title":"The effects of sGC stimulators on wound healing in the tight skin (TSK-1) mouse skin fibrosis model","volume":"74","author":"Haasbach","year":"2015","journal-title":"Ann. Rheum Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116302177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116302177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:35:20Z","timestamp":1760614520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116302177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":85,"alternative-id":["S0954611116302177"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.08.022","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}